Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F I Carroll

Showing results (141-150 of 208) with videos related to

Pageof 21
Sort By:
European Journal of Pharmacology|January 26, 1993
A comparison of (-)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of sigma 2 receptors in motor functionJ M Walker, W D Bowen, S L Patrick, et al.
Journal of Medicinal Chemistry|May 15, 1992
Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporterF I Carroll, Y Gao, P Abraham, et al.
Journal of Medicinal Chemistry|October 1, 1993
3-Aryl-2-(3'-substituted-1',2',4'-oxadiazol-5'-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transportersF I Carroll, J L Gray, P Abraham, et al.
Synapse (New York, N.Y.)|November 9, 2000
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninR B Rothman, M H Baumann, C M Dersch, et al.
Synapse (New York, N.Y.)|April 1, 1997
N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporterU Scheffel, J R Lever, P Abraham, et al.
Synapse (New York, N.Y.)|November 9, 2000
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.
Journal of Medicinal Chemistry|February 11, 1998
Synthesis and ligand binding of tropane ring analogues of paroxetineK I Keverline-Frantz, J W Boja, M J Kuhar, et al.
Biochemical and Biophysical Research Communications|November 30, 1992
Novel inhibitor of phospholipase A2 with topical anti-inflammatory activityK M Tramposch, S A Steiner, P L Stanley, et al.
Life Sciences|January 1, 1993
Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonistsR B Rothman, K M Becketts, L R Radesca, et al.
Synapse (New York, N.Y.)|April 1, 1997
RTI-352: a 3 alpha analogue of RTI-55 as an in vivo dopamine transporter binding ligandY Zhan, A M Saindane, U Scheffel, et al.
Pageof 21

Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
European Journal of Pharmacology|January 26, 1993
A comparison of (-)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of sigma 2 receptors in motor functionJ M Walker, W D Bowen, S L Patrick, et al.
Journal of Medicinal Chemistry|May 15, 1992
Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporterF I Carroll, Y Gao, P Abraham, et al.
Journal of Medicinal Chemistry|October 1, 1993
3-Aryl-2-(3'-substituted-1',2',4'-oxadiazol-5'-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transportersF I Carroll, J L Gray, P Abraham, et al.
Synapse (New York, N.Y.)|November 9, 2000
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninR B Rothman, M H Baumann, C M Dersch, et al.
Synapse (New York, N.Y.)|April 1, 1997
N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporterU Scheffel, J R Lever, P Abraham, et al.
Synapse (New York, N.Y.)|November 9, 2000
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.
Journal of Medicinal Chemistry|February 11, 1998
Synthesis and ligand binding of tropane ring analogues of paroxetineK I Keverline-Frantz, J W Boja, M J Kuhar, et al.
Biochemical and Biophysical Research Communications|November 30, 1992
Novel inhibitor of phospholipase A2 with topical anti-inflammatory activityK M Tramposch, S A Steiner, P L Stanley, et al.
Life Sciences|January 1, 1993
Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonistsR B Rothman, K M Becketts, L R Radesca, et al.
Synapse (New York, N.Y.)|April 1, 1997
RTI-352: a 3 alpha analogue of RTI-55 as an in vivo dopamine transporter binding ligandY Zhan, A M Saindane, U Scheffel, et al.
Pageof 21